Source:http://linkedlifedata.com/resource/pubmed/id/12509328
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
2003-1-1
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
0007-1250
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
182
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
81
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:12509328-Anti-Anxiety Agents,
pubmed-meshheading:12509328-Antipsychotic Agents,
pubmed-meshheading:12509328-Clozapine,
pubmed-meshheading:12509328-Drug Interactions,
pubmed-meshheading:12509328-Drug Therapy, Combination,
pubmed-meshheading:12509328-Fluvoxamine,
pubmed-meshheading:12509328-Humans,
pubmed-meshheading:12509328-Schizophrenia
|
| pubmed:year |
2003
|
| pubmed:articleTitle |
Adjunctive fluvoxamine with clozapine.
|
| pubmed:publicationType |
Letter,
Comment,
Research Support, Non-U.S. Gov't
|